Type 2 diabetes (T2D) and non-small cell lung cancer (NSCLC) each represent costly chronic diseases with substantial public health implications. A better understanding of the relationship between T2D treatments and NSCLC has many important implica...
Type 2 diabetes (T2D) and non-small cell lung cancer (NSCLC) each represent costly chronic diseases with substantial public health implications. A better understanding of the relationship between T2D treatments and NSCLC has many important implica...
